Arcadia Biosciences (FRA:17D) Marketable Securities : €4.77 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Arcadia Biosciences Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Arcadia Biosciences's Marketable Securities for the quarter that ended in Mar. 2024 was €4.77 Mil.

Arcadia Biosciences's annual Marketable Securities stayed the same from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.00 Mil) but then increased from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€4.70 Mil).

Arcadia Biosciences Marketable Securities Historical Data

The historical data trend for Arcadia Biosciences's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arcadia Biosciences Marketable Securities Chart

Arcadia Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

15.22

9.56

4.70

Arcadia Biosciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															-	4.64	4.77	4.70	4.77

Arcadia Biosciences Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Arcadia Biosciences (FRA:17D) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Arcadia Biosciences Marketable Securities Related Terms

Thank you for viewing the detailed overview of Arcadia Biosciences's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Arcadia Biosciences (FRA:17D) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Arcadia Biosciences Inc (FRA:17D) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

RKDA:USA

Address

5950 Sherry Lane, Suite 215, Dallas, TX, USA, 75225

Website

https://www.arcadiabio.com

Arcadia Biosciences Inc is a producer and marketer of innovative, plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements primarily in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care.

Arcadia Biosciences (FRA:17D) Headlines

No Headlines